AbbVie TodayABBVAbbVie$194.31 -0.44 (-0.23%) 52-Week Range$135.85▼$199.95Dividend Yield3.19%P/E Ratio57.66Price Target$198.00Add to WatchlistAbbVie NYSE: ABBV spooked the market in early October, but the sell-off is a buying opportunity. The critical takeaway is that only the earnings guidance was altered; the trim was small and offset by the cause. The cause is an increased expectation for intellectual property, R&D, and milestone acquisitions-related expenses that aid the pipeline and growth sustainabilit ...